NCT07066865View on ClinicalTrials.gov

Evaluation of the Safety and Effectiveness of omniLenz in Patient With Ocular Graft vs Host Disease

NACompletedINTERVENTIONAL
Enrollment

3

Participants

Timeline

Start Date

April 1, 2022

Primary Completion Date

April 1, 2024

Study Completion Date

April 1, 2024

Conditions
Ocular Graft Versus Host Disease
Interventions
DEVICE

omniLenz

sutureless dehydrated amniotic membrane (omnigen) mounted on contact lens (omnilenz)

Trial Locations (1)

Unknown

Farwanyia Hospital, Al Farwānīyah

All Listed Sponsors
lead

Farwaniya Hospital

OTHER_GOV